C Rischpler1, S G Nekolla. 1. Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
Abstract
CLINICAL/METHODICAL ISSUE: The positron emission tomography/magnetic resonance imaging (PET/MRI) technique represents a new hybrid imaging modality in nuclear cardiology. STANDARD RADIOLOGICAL METHODS: The standard radiological method in this field is PET/computed tomography (CT). METHODICAL INNOVATIONS: For morphological correlation MRI is used instead of CT. Furthermore, the creation of attenuation maps (μ-maps) has to be accomplished using MRI data. PERFORMANCE: For this new hybrid imaging modality only limited data are so far available, especially in the field of nuclear cardiology; however, the available data show a relatively good agreement between both modalities with the PET/CT as the modality of reference. ACHIEVEMENTS: In comparison to PET/CT a major advantage of PET/MRI is the lower radiation dose to the patient; however, the more complex workflow using this new imaging modality also has to be taken into account. Furthermore, some indications are still at an experimental stage using the PET/MRI. PRACTICAL RECOMMENDATIONS: In daily practice, PET/MRI should be considered especially in younger patients due to the lower exposure to radiation. Furthermore, there are some advantages for this modality in the field of nuclear cardiology, such as imaging of inflammatory myocardial processes (e.g. cardiac sarcoidosis) or myocardial viability imaging.
CLINICAL/METHODICAL ISSUE: The positron emission tomography/magnetic resonance imaging (PET/MRI) technique represents a new hybrid imaging modality in nuclear cardiology. STANDARD RADIOLOGICAL METHODS: The standard radiological method in this field is PET/computed tomography (CT). METHODICAL INNOVATIONS: For morphological correlation MRI is used instead of CT. Furthermore, the creation of attenuation maps (μ-maps) has to be accomplished using MRI data. PERFORMANCE: For this new hybrid imaging modality only limited data are so far available, especially in the field of nuclear cardiology; however, the available data show a relatively good agreement between both modalities with the PET/CT as the modality of reference. ACHIEVEMENTS: In comparison to PET/CT a major advantage of PET/MRI is the lower radiation dose to the patient; however, the more complex workflow using this new imaging modality also has to be taken into account. Furthermore, some indications are still at an experimental stage using the PET/MRI. PRACTICAL RECOMMENDATIONS: In daily practice, PET/MRI should be considered especially in younger patients due to the lower exposure to radiation. Furthermore, there are some advantages for this modality in the field of nuclear cardiology, such as imaging of inflammatory myocardial processes (e.g. cardiac sarcoidosis) or myocardial viability imaging.
Authors: Francis J Klocke; Michael G Baird; Beverly H Lorell; Timothy M Bateman; Joseph V Messer; Daniel S Berman; Patrick T O'Gara; Blase A Carabello; Richard O Russell; Manuel D Cerqueira; Martin G St John Sutton; Anthony N DeMaria; James E Udelson; J Ward Kennedy; Mario S Verani; Kim Allan Williams; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; David P Faxon; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell Journal: J Am Coll Cardiol Date: 2003-10-01 Impact factor: 24.094
Authors: V Schulz; I Torres-Espallardo; S Renisch; Z Hu; N Ojha; P Börnert; M Perkuhn; T Niendorf; W M Schäfer; H Brockmann; T Krohn; A Buhl; R W Günther; F M Mottaghy; G A Krombach Journal: Eur J Nucl Med Mol Imaging Date: 2010-10-05 Impact factor: 9.236
Authors: Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna Journal: J Nucl Med Date: 2007-07 Impact factor: 10.057
Authors: Matthew W Parker; Aline Iskandar; Brendan Limone; Andrew Perugini; Hyejin Kim; Charles Jones; Brian Calamari; Craig I Coleman; Gary V Heller Journal: Circ Cardiovasc Imaging Date: 2012-10-10 Impact factor: 7.792
Authors: Axel Martinez-Möller; Michael Souvatzoglou; Gaspar Delso; Ralph A Bundschuh; Christophe Chefd'hotel; Sibylle I Ziegler; Nassir Navab; Markus Schwaiger; Stephan G Nekolla Journal: J Nucl Med Date: 2009-03-16 Impact factor: 10.057
Authors: Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère Journal: Jpn J Radiol Date: 2018-03-10 Impact factor: 2.374